Mesenchymal Stem Cell Therapy in Stroke: A Systematic Review of Literature in Pre-Clinical and Clinical Research
Exogenous stem cell therapy (SCT) has been recognized recently as a promising neuroregenerative strategy to augment recovery in stroke survivors. Mesenchymal stem cells (MSCs) are the primary source of stem cells used in the majority of both pre-clinical and clinical studies in stroke. In the absenc...
Main Authors: | Haiqing Zheng, Bin Zhang, Pratik Y. Chhatbar, Yi Dong, Ali Alawieh, Forrest Lowe, Xiquan Hu, Wuwei Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-12-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/0963689718806846 |
Similar Items
-
Data Synthesis in Meta-Analysis may Conclude Differently on Cognitive Effect From Transcranial Direct Current Stimulation
by: Pratik Y. Chhatbar, et al.
Published: (2015-09-01) -
Integrating tDCS into routine inpatient rehabilitation practice to boost post-stroke recovery
by: Shreyansh Shah, et al.
Published: (2020-07-01) -
Systematic Review on the Involvement of the Kynurenine Pathway in Stroke: Pre-clinical and Clinical Evidence
by: Gabriela D. Colpo, et al.
Published: (2019-07-01) -
Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies
by: Agnese Gugliandolo, et al.
Published: (2020-11-01) -
The Proof is in the Pudding: Does tDCS Actually Deliver DC Stimulation?
by: Pratik Y. Chhatbar, et al.
Published: (2016-07-01)